Stefania Girotto

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Cognitive Decline

Top Venues

Journal of medicinal chemistry

International journal of molecular sciences

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Beatrice Balboni, Roberto Marotta, Francesco Rinaldi, Giulia Milordini, Giulia Varignani, Stefania Girotto, Andrea Cavalli
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution. Communications biology 7 (1) (2024)
Beatrice Balboni, Roberto Marotta, Francesco Rinaldi, Giulia Milordini, Giulia Varignani, Stefania Girotto, Andrea Cavalli
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution. Communications biology 7 (1) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry (2024)
Beatrice Balboni, Roberto Marotta, Francesco Rinaldi, Giulia Milordini, Giulia Varignani, Stefania Girotto, Andrea Cavalli
An integrative structural study of the human full-length RAD52 at 2.2 Å resolution. Communications biology 7 (1) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Nicoletta Brindani, Linh M Vuong, Maria Antonietta La Serra, Noel Salvador, Andrea Menichetti, Isabella Maria Acquistapace, Jose Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy. Journal of medicinal chemistry 67 (12) (2024)
Beatrice Balboni, Francesco Rinaldi, Viola Previtali, Andrea Ciamarone, Stefania Girotto, Andrea Cavalli
Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies. Cancers 15 (6) (2023)
Beatrice Balboni, Francesco Rinaldi, Viola Previtali, Andrea Ciamarone, Stefania Girotto, Andrea Cavalli
Novel Insights into RAD52's Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies. Cancers 15 (6) (2023)
Nicoletta Brindani, Linh M Vuong, Isabella Maria Acquistapace, Maria Antonietta La Serra, José Antonio Ortega, Marina Veronesi, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti, Anand K Ganesan, Marco De Vivo
Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer. Journal of medicinal chemistry (2023)
Irene Brusa, Elvira Sondo, Emanuela Pesce, Valeria Tomati, Dario Gioia, Federico Falchi, Beatrice Balboni, Jose Antonio Ortega Martínez, Marina Veronesi, Elisa Romeo, Natasha Margaroli, Maurizio Recanatini, Stefania Girotto, Nicoletta Pedemonte, Marinella Roberti, Andrea Cavalli
Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5. Journal of medicinal chemistry (2023)
Beatrice Balboni, Mirco Masi, Walter Rocchia, Stefania Girotto, Andrea Cavalli
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier? International journal of molecular sciences 24 (8) (2023)
Beatrice Balboni, Mirco Masi, Walter Rocchia, Stefania Girotto, Andrea Cavalli
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier? International journal of molecular sciences 24 (8) (2023)
Beatrice Balboni, Mirco Masi, Walter Rocchia, Stefania Girotto, Andrea Cavalli
GSK-3β Allosteric Inhibition: A Dead End or a New Pharmacological Frontier? International journal of molecular sciences 24 (8) (2023)
Fabrizio Schipani, Marcella Manerba, Roberto Marotta, Laura Poppi, Arianna Gennari, Francesco Rinaldi, Andrea Armirotti, Fulvia Farabegoli, Marinella Roberti, Giuseppina Di Stefano, Walter Rocchia, Stefania Girotto, Nicola Tirelli, Andrea Cavalli
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination. International journal of molecular sciences 23 (15) (2022)
Beatrice Balboni, Shailesh Kumar Tripathi, Marina Veronesi, Debora Russo, Ilaria Penna, Barbara Giabbai, Tiziano Bandiera, Paola Storici, Stefania Girotto, Andrea Cavalli
Identification of Novel GSK-3β Hits Using Competitive Biophysical Assays. International journal of molecular sciences 23 (7) (2022)
Greta Bagnolini, Beatrice Balboni, Fabrizio Schipani, Dario Gioia, Marina Veronesi, Francesca De Franco, Cansu Kaya, Ravindra P Jumde, Jose Antonio Ortega, Stefania Girotto, Anna Katharina Herta Hirsch, Marinella Roberti, Andrea Cavalli
Identification of RAD51-BRCA2 Inhibitors Using N -Acylhydrazone-Based Dynamic Combinatorial Chemistry. ACS medicinal chemistry letters 13 (8) (2022)